Pharma & Biotech

Natera's latest quarterly earnings report has sent its stock on a volatile ride, with investors responding enthusiastically to dramatically raised...

Assembly Biosciences shares continue to demonstrate impressive performance in the market, building on recent gains with strong technical indicators and...

Kura Oncology has achieved a significant regulatory milestone with the U.S. Food and Drug Administration granting full approval for its...

Altimmune finds itself at a critical juncture this quarter, with its shares potentially on the verge of a significant move....

The biotechnology sector has identified its latest standout performer: Axsome Therapeutics. This pharmaceutical firm is rapidly establishing itself as a...

The animal health sector's former high-flyer is confronting significant growth challenges. With market analysts systematically lowering their projections, the equity...

Scientific instrument manufacturer Bruker finds itself at a critical juncture. Despite delivering a quarterly earnings surprise, the company's stock faced...

Biogen has secured two significant advancements that could reinvigorate the biotechnology company's growth trajectory. Recent developments include a streamlined treatment...

Investors in Bristol-Myers Squibb encountered a significant market downturn as the pharmaceutical giant and its collaborator, Johnson & Johnson, terminated...

Investor attention is firmly fixed on Arrowhead Pharmaceuticals this week as the biotechnology firm approaches two significant milestones that could...